Epitalon
Synthetic AEDG tetrapeptide studied in telomere, pineal and ageing-related research.
Limited human evidenceExplore this ingredient →← All stacks & combinationsINGREDIENT INGREDIENT POPULAR GOALS THE COMMUNITY RATIONALE THE OPEN QUESTION EPITALON DSIP Human study · DSIP alone Regulatory guidance · ingredient safety
Community combination
Epitalon + DSIP
Sleep and the body clock connect Epitalon + DSIP to wider questions about healthy ageing. That shared theme does not yet establish a benefit from taking them together.
Sleep & MoodLongevity & Ageing
01
THE BUILDING BLOCKS
What’s in it?
DSIP
Delta sleep-inducing peptide investigated in older human sleep studies and neuroendocrine research.
Limited and inconsistent human evidenceExplore this ingredient →The ingredients listed here do not specify a particular product or mixing ratio. Pre-mixed products may differ from the formulations used in research.
02
PEOPLE & EXPERIENCE
Why this combination is discussed
Sleep and the body clock connect Epitalon + DSIP to wider questions about healthy ageing. That shared theme does not yet establish a benefit from taking them together.
Sleep & MoodLongevity & Ageing
A pairing discussed in relation to sleep, the body’s daily rhythm and ageing.
Sleep quality, the body clock and lifespan are different outcomes. Interest in these areas does not yet establish a benefit from combining the two ingredients.
Community experience can explain why a pairing has become popular. It cannot show whether the ingredients work better together or whether a mixed product is stable, accurately dosed or safe.
03
THE REASON FOR INTEREST
Why people combine them
A pairing discussed in relation to sleep, the body’s daily rhythm and ageing.
How their research overlaps
Sleep quality, the body clock and lifespan are different outcomes. Interest in these areas does not yet establish a benefit from combining the two ingredients.
The individual profiles explain each ingredient’s potential benefits and research. Even when their effects seem complementary, studies are needed to find out whether using them together adds a benefit.
04
No human combination study found in this searchWHAT THE RESEARCH CAN SUPPORT
Evidence for this combination
We did not find a human study testing these ingredients together in our targeted search. That leaves their combined benefits and safety uncertain; it does not show that the pairing is ineffective.
The small DSIP sleep study covers DSIP alone. It does not show whether adding Epitalon offers a benefit or whether the pair affects lifespan.
Explore the sources below ↓05
RESEARCH & COMMUNITY CONTEXT
Doses & duration
Start with each ingredient—not an invented combined dose
No validated combined starting dose exists. The cards below preserve the practical structure people look for while keeping each ingredient’s reported pattern separate.
Anecdotal / unvalidated · no established human longevity dose
- Starting point discussed
- Community descriptions often begin around 5 mg per day; 10 mg per day also appears, usually by subcutaneous injection.
- Duration / cycle
- Short 10–20-day courses are more commonly discussed than continuous use.
- Continuation / break
- A long pause—often several months—may be described before another course, but no evidence-based repeat interval exists.
Anecdotal / unvalidated · historic IV evidence differs
- Starting point discussed
- Community descriptions often begin around 100 mcg near bedtime; 200–300 mcg is also discussed. This is not derived from a validated modern human protocol.
- Duration / cycle
- A brief 10–14-night trial window is commonly described, sometimes with intermittent use rather than nightly continuation.
- Continuation / break
- No validated step-up, continuous-use, tolerance-management or break schedule exists.
Using two ingredients in the same period and mixing them in one vial or syringe are different questions. Separate schedules cannot establish compatibility, interactions or a safe combined total.
06
WHAT REMAINS UNCERTAIN
Safety & uncertainties
- The combination needs its own safety research, including possible interactions and side effects.
- What a product contains, how it is made and how it is used all matter. Products sold under the same name may differ.
- A clinician can assess how existing medicines or health conditions affect the risks. These pages provide general information, not personal treatment advice.
07
FOLLOW THE EVIDENCE
Sources & search record
Last source check: 14 September 2026
Each link explains what it covers: the combination itself, an individual ingredient or safety information. A trial record and a paper can describe the same study.
Bes et al., 1992 — DSIP in chronic insomnia ↗
A small double-blind study of DSIP alone. We checked the available study listing and summary, not the full paper.
FDA: peptide compounding safety concerns ↗
Safety information about individual ingredients, rather than the combination. This is US guidance, not a statement of UK legal status.
About this search
We used targeted web searches for ingredient pairs, including searches focused on PubMed and ClinicalTrials.gov. We followed relevant papers, research reviews and FDA safety information, checking whether the ingredients were actually given together and how they were used. Some full papers were unavailable, so we relied on their published summaries. Web searches can miss studies: this was a targeted source check, not an exhaustive or systematic review, a clinical assessment or a review of UK regulation. The links below let you explore further; search results are not evidence on their own.
Search terms used
- "Epitalon" "DSIP" study trial
- "Epithalon" "delta sleep" trial
- "Epithalon" "DSIP" site:pubmed.ncbi.nlm.nih.gov
- site:clinicaltrials.gov ("Epitalon" OR "Epithalon") ("DSIP" OR "delta sleep")
Search for these ingredients together:
Studies may use different names for the same ingredient. The search terms above show which alternatives we checked. Community experiences can explain interest in a stack, but we did not count anecdotes or seller claims as clinical studies.